Total Funding
17
Total FundingEquity Crowdfunding raised
Growth Score
pts
Heat Score
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Batu Biologics is a preclinical biopharmaceutical company focusing on developing and commercializing
Thomas Ichim: Founder, Chief Scientific OfficerPast Role: Therapeutic Solutions International, Director
Gerry Berg: Chief Financial Officer
About the Company
Batu Biologics is a preclinical biopharmaceutical company focusing on developing and commercializing allogeneic cell therepies in the area of immune modulation. Our products are centered around the idea of creating or breaking immune tolerance. The company is currently in the preclinical stages of drug development for its two flagship products:
Immstem and Vallovax. Batu Biologics has filed two provisional patents in the field of cancer immunotherapy and plans to significantly expand its IP
